Anabasum: A Potential Treatment for Systemic Sclerosis
Corbus CMO Dr. Barbara White, CEO Dr. Yuval Cohen and Dr. Michael Whitfield of Dartmouth University discuss the Phase 2 results of anabasum in systemic sclerosis and its potential to improve the quality of life for patients. Watch now >>